CGG triplet repeat located 4 bp upstream of the first methionine codon, in the 5' UTR
only one of two putative Gli-binding sites identified in the promoter region is functional, and the transactivating Gli proteins, GLI1, GLI2 and GLI3, bind and enhance transcription through this site
three ZNF431 binding sites in the promoter
MAPPING
cloned
Y
linked
N
status
confirmed
Map
see NBCCS
RNA
TRANSCRIPTS
type
messenger
text
regulated by three independent promoters generating transcripts with alternative first exons
an alternative exon, exon 12b, located between exon 12 and 13 having an in-frame stop codon, the mRNA isoform containing this exon (Patched12b) encodes a truncated patched-1 protein
identification
nb exons
type
bp
product
Protein
kDa
AA
specific expression
Year
Pubmed
24
splicing
7911
-
1446
colon, testis
-
exon 1a
variant a prime or PTCHl2
-
splicing
-
-
-
specifically upregulated in nodular BCCs
-
inhibiting SMO activity.
24
splicing
7957
160.5
1447
colon, testis, brain, ovary
-
exon 1b, variant 1b or PTCHl
methylated in some cases of medulloblastoma
24
splicing
7675
-
1295
-
-
exon 1c, variant 1c or PTCHs
N-terminally truncated lacking the first transmembrane domain
exon 1c transcription is upregulated by HH signaling, but the resulting PTCH1-1C protein has a lower capacity for pathway inhibition than PTCH1-1B
24
splicing
7658
-
1295
-
-
exon 1c', variant c prime or PTCHs
N-terminally truncated lacking the first transmembrane domain
24
splicing
7831
-
1295
-
-
exon 1e, variant 1e or PTCHs
N-terminally truncated lacking the first transmembrane domain
24
splicing
8065
-
1381
-
-
exon 1a', variant a' ou PTCH2
24
splicing
7757
-
1295
widely
-
exon 1d, variant 1d or PTCHs
-
splicing
879
-
106
expressed in some of the medulloblastoma tissues and cell lines
-
exon 1-5, exon 10 and exon 12b specfically expressed in brain and heart, especially in cerebellum
having a dominant negative effect on PATCH1
important role in the pathogenesis of medulloblastoma as well as brain development
EXPRESSION
Type
widely
expressed in
(based on citations)
organ(s)
System
Organ level 1
Organ level 2
Organ level 3
Organ level 4
Level
Pubmed
Species
Stage
Rna symbol
Digestive
intestine
large intestine
colon
highly
Hearing/Equilibrium
ear
highly
Nervous
brain
hindbrain
cerebellum
Rattus norvegicus
Fetal
brain
hindbrain
cerebellum
Rattus norvegicus
Adult
brain
limbic system
hippocampus
highly
Rattus norvegicus
Adult
brain
limbic system
hippocampus
highly
Rattus norvegicus
Fetal
Respiratory
lung
moderately
Urinary
kidney
tissue
System
Tissue
Tissue level 1
Tissue level 2
Level
Pubmed
Species
Stage
Rna symbol
Muscular
striatum
skeletal
cells
System
Cell
Pubmed
Species
Stage
Rna symbol
Nervous
neuron
Rattus norvegicus
Nervous
Purkinje cell
Rattus norvegicus
Reproductive
spermatocyte
Homo sapiens
cell lineage
cell lines
fluid/secretion
at STAGE
physiological period
embryo, pregnancy
Text
ventral neural tube, somites, limb bud, placenta
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
N and C cytoplasmic termini
twelve membrane spanning segments, five of them (TM2 to TM6) forming a sterol sensing domain(SSD)
a proline-rich motif in the C terminal region
two large hydrophilic extracellular loops
two functional GLI-binding sequences
conjugated
GlycoP
HOMOLOGY
interspecies
homolog to
Drosophila segment polarity gene patched (PTC)
playing a role in the development of basal cell cancer
regulates hedgehog signaling at the primary cilium, inhibiting the Hh pathway by excluding SMOH and also allows cilia to function as chemosensors for the detection of extracellular SHH
PTCH1 and SMO are present in the processes and growth cones of immature neurons
key regulator of embryonic development, acting through the sonic hedgehog (SHH) signaling pathway
also acts as a lineage-dependent oncogene
essential role for ligand-dependent feedback inhibition of vertebrate HH signaling governed collectively by PTCH1, PTCH2 and HHIP
PTCH1 and PTCH2 co-operate in regulating cellular responses to SHH
PTCH1/PTCH2 mediate likely secretion of a SMO-inhibitory cholesterol precursor
PTCH1 and the integral membrane protein 2A (ITM2A) inhibit autophagy by reducing autolysosome formation
CELLULAR PROCESS
PHYSIOLOGICAL PROCESS
development
text
embryonic patterning
PATHWAY
metabolism
signaling
signal transduction
GLI1 and PTCH1 are both components and transcriptional targets of the SHH pathway
a component
INTERACTION
DNA
RNA
small molecule
protein
receptor for SHH signaling proteins (negative regulator of the HH-signaling pathway by repressing downstream signaling by the coreceptor smoothened (SMOH))
regulator of HH (role of splicing variation and promoter choice for HH signaling regulation)
interacting with SCUBE2
Sertoli cells coordinate DHH-dependent spermatogenesis events via PTCH1 and SMO prior to the first meiotic division and in postmeiotic (haploid) cells, particularly during the first half of spermiogenesis
GPC5 binds to both Hh and PTCH1 through its glycosaminoglycan chains)
direct transcriptional target of ZNF431
PTCH1 intracellular domain (ICD7) interacted with most components of the CUL2 (CUL2)-based E3 ligase complex, including ELOC, ELOB, ZYG11B, and CUL2 itself
PTCH1 is a novel CHL1-binding protein and CHL1 interacts with the first extracellular loop of PTCH1 via its extracellular domain
HH reciprocally controls trafficking of SMO and PTC through the SMURF family of E3 ubiquitin ligases
inactivation of PTCH1 by HH likely allows a transmembrane sterol to access this seven-transmembrane site (potentially through a hydrophobic tunnel), which drives the activation of SMO
cell & other
REGULATION
activated by
hedgehog proteins (transcriptional activation mediated via the HH-signaling pathway is dependent on the single functional Gli-binding site)
inhibited by
SHH by binding to it at the cilium and inducing its internalization, degradationor movements to other regions of the plasma membrane
in desmoplastic medulloblastoma and in basal cells carcinoma
tumoral
 
 
 
loss of function
in medulloblastoma and skin tumors
tumoral
somatic mutation
 
 
 
in basal cell carcinoma (BCC) of the skin
tumoral
 
LOH
 
 
in ovarian tumors, benign or malignant, sporadic basal cell carcinoma, small cell lung carcinoma, lymph node metastasis of primary breast cancer
tumoral
 
deletion
 
 
in papillary thyroid carcinoma, in trichoepithelioma, sebaceous nevus, non-melanoma skin cancer, basal cell carcinoma
tumoral
germinal mutation
 
 
 
in bladder carcinoma
tumoral
somatic mutation
 
 
 
in keratocystic odontogenic tumors
constitutional
 
amplification
 
 
duplication in a family with microcephaly and mild developmental delay
tumoral
 
LOH
 
 
in nonsyndromic or sporadic cardiac fibroma
tumoral
 
 
--other
 
aberrant methylation of the PTCH1 promoter may be an early, initiating event of colon carcinogenesis
constitutional
 
 
 
loss of function
concomitant loss of PTCH1 and PTCH2 activity inhibits epidermal lineage specification and differentiation
Susceptibility
to basal cells carcinoma
Variant & Polymorphism
SNP
, insertion/deletion
, other
increasing the risk of basal cells carcinoma
Candidate gene
in a mouse model, APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome (;
for Wilms tumor in del 9q22 patients
Marker
alterations of FANCC and PTCH1 could be used as molecular marker for early diagnosis and prognosis of head and neck squamous cell carcinoma (HNSCC)
Therapy target
ANIMAL & CELL MODELS
inhibition of Shh signaling pathway exacerbated rat ischemic damage caused by permanent middle cerebral artery occlusion, which may be correlated with down-regulated expression of Gli1, Ptch1 and Sod1
inactivation of Ptch1 in mice leads to formation of gastrointestinal stromal tumor-like tumors that express Pdgfr&